Grape and Blueberry Extract Mixture for Acute Cognitive Enhancement

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current solutions for improving cognitive performance, such as pharmaceutical stimulants and chronic nutritional supplements, are either unsafe, restrictive, or ineffective when taken in a single dose, and existing acute administration studies with flavonoids have shown mixed and often negative results.

Innovation Solution

A composition comprising a mixture of molecules from Vitis vinifera and Vaccinium angustifolium, specifically with at least 1% catechins and/or epicatechins, 5 ppm ferulic acid, and 200 ppm resveratrol, administered as a single dose to enhance cognitive functions in humans and animals.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If flavonoids are taken chronically for several weeks, then cognitive function is improved, but the solution becomes cumbersome and expensive requiring long-term commitment

Engineering Contradiction:
Improvecognitive function improvementVSAvoidchronic dosing duration
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The patent applies preliminary action by formulating a single-dose composition with pre-optimized flavonoid mixtures (including specific ratios of catechins, epicatechins, and other polyphenols) that are prepared in advance to achieve immediate cognitive enhancement without requiring chronic administration. The composition is designed to be taken once before a specific event (e.g., exam), eliminating the need for long-term commitment while maintaining effectiveness.

Inventive Principle:
Principle #10Preliminary action

2Reliability

If high doses of flavonoids are administered in a single dose, then acute cognitive improvement is achieved, but the dose becomes very high and potentially unsafe

Engineering Contradiction:
Improveacute cognitive improvementVSAvoidflavonoid dose amount
Core Design Contradiction:
ReliabilityVSQuantity of substance

Solution Approach 1:

The patent applies parameter changes by optimizing the composition of flavonoid mixtures, specifically adjusting the ratios and types of polyphenols (catechins, epicatechins, and other flavonoids) to achieve acute cognitive enhancement at safe, moderate doses. The composition is formulated with specific concentrations of each component to maximize effectiveness while minimizing risk, avoiding the need for very high single doses.

Inventive Principle:
Principle #35Parameter changes

3Reliability

If existing commercial nutritional solutions are used, then cognitive performance is improved, but they require chronic dosing which is cumbersome and expensive

Engineering Contradiction:
Improvecognitive performance improvementVSAvoiddosing regimen complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent applies segmentation by dividing the chronic dosing regimen into a single, optimized dose that contains all necessary flavonoid components in pre-calculated ratios. Instead of requiring continuous supplementation over weeks, the composition is segmented into a one-time administration that delivers the full therapeutic benefit, simplifying the user experience from ongoing commitment to single-use convenience.

Inventive Principle:
Principle #1Segmentation

4Speed

If flavonoid mixtures are taken in a single dose, then immediate effect is desired, but the activity varies greatly depending on type of flavonoid, dose and age

Engineering Contradiction:
Improveonset speed of effectVSAvoidconsistent cognitive effect
Core Design Contradiction:
SpeedVSReliability

Solution Approach 1:

The patent applies local quality by tailoring the specific composition of flavonoid mixtures to include particular types and ratios of polyphenols (catechins, epicatechins, and other flavonoids) that are most effective for acute cognitive enhancement. The composition is locally optimized for immediate effect while accounting for variations in flavonoid types, ensuring consistent and reliable cognitive improvement across different users and age groups.

Inventive Principle:
Principle #3Local quality

Data Source

PatentEP3883551B1Single-dose use of a composition comprising a particular mixture of grape extract and blueberry extract
Publication Date: 2023.09.13 ACTIV INSIDE
  • EP3883551B1 patent drawingFigure 1~2D
  • EP3883551B1 patent drawingFigure 3~4

AI summary

The invention concerns the use of a composition comprising at least a mixture of molecules obtained from Vitis vinifera and Vaccinium angustifolium, the mixture comprising: - at least 1% catechins and/or epicatechins, the percentage being given by weight relative to the total weight of the mixture, - at least 5 ppm (parts per million in the mixture) of ferulic acid, and - at least 200 ppm of resveratrol, as a single dose in humans or animals in order to improve or maintain cognitive functions.